Literature DB >> 3550417

Respiratory system in amyotrophic lateral sclerosis.

S R Braun.   

Abstract

Failure of the respiratory system is the most common cause of death in amyotrophic lateral sclerosis. This is due to weakened respiratory musculature resulting in respiratory failure, ineffective cough, and failure to protect the lungs from aspiration. Treatment is only supportive at present, but mechanical ventilation with either negative or positive pressure offer some life-extending possibilities. The respiratory system should be closely monitored as early identification of problems may allow better insight into the immediate prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3550417

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  5 in total

1.  Motor neuron disease presenting as acute respiratory failure: a clinical and pathological study.

Authors:  R Chen; F Grand'Maison; M J Strong; D A Ramsay; C F Bolton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

Review 2.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  The Benefit of Non-invasive Ventilation in Motor Neuron Disease.

Authors:  Laura J Walsh; Desmond M Murphy
Journal:  Open Respir Med J       Date:  2020-12-15

4.  Use of non-invasive ventilation in motor neuron disease - a retrospective cohort analysis.

Authors:  Laura J Walsh; Kevin F Deasy; Fernando Gomez; Elizabeth O'Sullivan; Joseph Eustace; Aisling M Ryan; Desmond M Murphy
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 3.115

5.  Impaired Mitophagy Plays a Role in Denervation of Neuromuscular Junctions in ALS Mice.

Authors:  Robert S Rogers; Sudheer Tungtur; Tomohiro Tanaka; Lisa L Nadeau; Yomna Badawi; Hua Wang; Hong-Min Ni; Wen-Xing Ding; Hiroshi Nishimune
Journal:  Front Neurosci       Date:  2017-08-25       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.